Archives

by in
Entry Author Date Location
BSX Meets With Much Approval, Biogen and Icahn Set the (Showdown) Date, Fate’s Fate Revealed, Win Free Stuff, & More Life Sciences News 05/14/08 Boston
Novartis Increases Stake in Alnylam 05/08/08 Boston
Three Luminaries, Two Third Revolutions, and One Nice Suit: An Xconomy Forum on the Future of Life Sciences in New England 05/02/08 Boston
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals 05/01/08 Boston
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News 04/23/08 Boston
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million 04/17/08 Boston
In Latest Local Venture Philanthropy Deal, Cystic Fibrosis Foundation Pledges up to $37.7 More to Epix 04/07/08 Boston
Mello RNAi Firm RXi Pharmaceuticals Has Wild Ride on First Day of Trading 03/12/08 Boston
Thermo Fisher Simplifies RNAi Delivery 03/10/08 Boston
Biogen’s Busy Week, Alnylam’s Big Announcement, Targanta’s and Momenta’s Growing Executive Ranks, & More Life Sciences News 03/05/08 Boston
Alnylam Touts Early Evidence of RNAi Drug Efficacy 02/29/08 Boston
Alnylam’s John Maraganore Anticipates More RNAi Deals and Startups in “Unparalleled” Environment for Biotech 01/07/08 Boston
Of Red Wine, Robotics, and What Folks Would Do As Governor—Xconomy’s Forum Sparks Debate on the Future of Innovation in New England 12/06/07 Boston
Dicerna Officially Founded 11/14/07 Boston
Will it Rain RNAi Companies? Dicerna Co-Founder John Rossi Says New IP Opens Avenues 11/06/07 Boston
RNAi Firms Find a New Rival (and Partner) in an Old Technology 10/04/07 Boston
Alnylam and Merck Go Their Separate Ways, TransMedics Files to Go Public, ZipCar Reservation System Ready to Go Anywhere, and More 09/24/07 Boston
Mass Biotech Council’s Image Troubles, Boston Scientific’s Mixed Bag, Another Big IPO in the Offing, and More 09/10/07 Boston
Follow-Up: Alnylam’s Biodefense Contract the Program’s Largest 08/10/07 Boston
More Government Dollars for Alnylam Biodefense Initiative 08/09/07 Boston
Page 2 of 2 « previous page

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.